- 现金
- 9043 元
- 精华
- 4
- 帖子
- 4485
- 注册时间
- 2004-7-18
- 最后登录
- 2018-8-18
|
StephenW 发表于 2010-11-22 13:07
回复 IC 的帖子
"證實其具有抗腫瘤" If you read the article cited, no proof is offered. My opinion on ...
www.jleukbio.org/content/78/2/533.fullABSTRACT
Ganoderma lucidum, a fungus native to China, has been widely used to promote health and longevity in the Chinese. The polysaccharide component with a branched (1→6)-ß-D-glucan moiety of G. lucidum (PS-G) has been reported to exert anti-tumor activity and activation of natural killer cells. In this study, we investigated the effects of PS-G on human monocyte-derived dendritic cells (DC). Treatment of DC with PS-G resulted in the enhanced cell-surface expression of CD80, CD86, CD83, CD40, CD54, and human leukocyte antigen (HLA)-DR, as well as the enhanced production of interleukin (IL)-12p70, p40, and IL-10 and also IL-12p35, p40, and IL-10 mRNA expression, and the capacity for endocytosis was suppressed in DC. In addition, treatment of DC with PS-G resulted in enhanced T cell-stimulatory capacity and increased T cell secretion of interferon-γ and IL-10. Neutralization with antibodies against Toll-like receptor (TLR)-4 inhibited the PS-G-induced production of IL-12 p40 and IL-10, suggesting a vital role for TLR-4 in signaling DC upon incubation with PS-G. Further study showed that PS-G was able to augment inhibitor of κB (IκB) kinase and nuclear factor (NF)-κB activity and also IκBα and p38 mitogen-activated protein kinase (MAPK) phosphorylation. Further, inhibition of NF-κB by helenalin and p38 MAPK by SB98059 prevented the effects of PS-G in the expression of CD80, CD86, CD83, CD40, CD54, and HLA-DR and production of IL-12p70, p40, and IL-10 in various degrees. Taken together, our data demonstrate that PS-G can effectively promote the activation and maturation of immature DC, suggesting that PS-G may possess a potential in regulating immune responses.
REFERENCES
1
- Miyazaki, T., Nishijima, M. (1981) Studies on fungal polysaccharides, XXVII. Structural examination of a water-soluble, anti-tumor polysaccharide of Ganoderma lucidumChem. Pharm. Bull. (Tokyo)29,3611-3616[Medline]
2
- Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S. S., Shiao, M. S., Ho, C. K. (1997) The anti-tumor effect of Ganoderma lucidium is mediated by cytokines released from activated macrophages and T lymphocytes Int. J. Cancer70,699-705[CrossRef][Medline]
3
- Furusawa, E., Chou, S. C., Furusawa, S., Hirazami, A., Dang, Y. (1992) Anti-tumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergenic mice Phytother. Res.6,300-304[CrossRef]
4
- Lee, S. S., Wei, Y. H., Chen, C. F., Wang, S. Y., Chen, K. Y. (1995) Antitumor effects of Ganoderma lucidumJ. Chin. Med.6,1-12
5
- Won, S. J., Lee, S. S., Ke, Y. H., Lin, M. T. (1989) Enhancement of spenic NK cytotoxic activity by extracts of Ganoderma lucidum mycelium in mice J. Biomed. Lab. Sci.2,201-213
6
- Hsu, M. J., Lee, S. S., Lin, W. W. (2002) Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway J. Leukoc. Biol.72,207-216[Abstract/Free Full Text]
7
- Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity Nature392,245-252[CrossRef][Medline]
8
- Cella, M., Sallusto, F., Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells Curr. Opin. Immunol.9,10-16[CrossRef][Medline]
9
- Cella, M., Pinet Engering, A., Pieters, J., Lanzavecchia, A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells Nature388,782-787[CrossRef][Medline]
10
- Sallusto, F., Cella, M., Danieli, C., Lanzavecchia, A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products J. Exp. Med.182,389-400[Abstract/Free Full Text]
11
- Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., van Kooten, C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking J. Exp. Med.180,1263-1272[Abstract/Free Full Text]
12
- Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., Vogel, J. C. (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA J. Immunol.161,3042-3049[Abstract/Free Full Text]
13
- Yoshimura, S., Bondeson, J., Foxwell, B. M., Brennan, F. M., Feldmann, M. (2001) Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines Int. Immunol.13,675-683[Abstract/Free Full Text]
14
- Ardeshna, K. M., Pizzey, A. R., Devereux, S., Khwaja, A. (2000) The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells Blood96,1039-1046[Abstract/Free Full Text]
15
- Sallusto, F., Lanzavecchia, A. (1994) Efficent presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulation factor plus interleukin 4 and downregulated by tumor necrosis factor αJ. Exp. Med.179,1109-1118[Abstract/Free Full Text]
|
|